Skip to the page

Data / Form D filings / ValenzaBio, Inc.

ValenzaBio, Inc.: Form D filings

ValenzaBio, Inc., a company in Bethesda, MD, filed 2 Form D notices with the SEC between 2020 and 2021. The latest, on April 9, 2021, reports $79.4 million sold of a $79.4 million offering to 13 investors.

Find out what ValenzaBio, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6701 DEMOCRACY BLVD, SUITE 300, Bethesda, MD, 20817
Phone
(301) 755-9900
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1804522

The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 9, 2021New notice$79,374,978$79,374,978$013Mar 25, 2021sec.gov
Feb 28, 2020New notice$15,500,000$14,499,997$1,000,0033Feb 14, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
James SilvermanDirector
David MaizenbergExecutive Officer, Director
John DouxDirector
Patrick CrutcherExecutive Officer, Director

Other companies in Maryland that filed recently

Every Form D from the week of Apr 5, 2021 · All recent filings in Maryland · All recent Other filings

Read from SEC EDGAR. Amount sold is what ValenzaBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.